Frontiers in Cancer Immunotherapy

Topics include immunometabolism, resistance to immunotherapy, in vivo immune engineering, emerging therapeutic modalities, ageing and immune dysfunction, and cell therapy for AML. The programme features keynote lectures by Bernard Fox (Providence Cancer Institute), Elizabeth Jaffee (Johns Hopkins Medicine) and Crystal Mackall (Stanford Medicine), plenary talks, industry updates, short talks selected from abstracts and a panel on moving discoveries from bench to clinic. Presented by The New York Academy of Sciences' Cancer and Signaling Discussion Group, it runs in person and virtually.